Back to Freepaper Session

Visual function after bilateral implantation of ReSTOR vs FINEvision multifocal IOLs

Session Details

Session Title: Multifocal Technology and Comparative studies

Session Date/Time: Tuesday 08/10/2013 | 08:00-10:30

Paper Time: 09:12

Venue: Auditorium (First Floor)

First Author: : N.Bauer THE NETHERLANDS

Co Author(s): :    F. van den Biggelaar   A. al Dulaimi   R. Nuijts        

Abstract Details

Purpose:

To prospectively evaluate postoperative visual and refractive parameters in a randomized clinical trial of subjects bilaterally implanted with the Finevision (micro F) trifocal IOL or the AcrySof® IQ ReSTOR® +3.

Setting:

University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands.

Methods:

22 adult subjects (44 eyes) with cataract and ? 1.00D of corneal astigmatism were randomized to receive bilateral implantation of either Finevision (micro F) trifocal (Physiol, Liege) IOLs or AcrySof IQ ReSTOR +3 add (Alcon, Fort Worth) IOLs. Refractive and visual outcomes were measured preoperatively and postoperatively (1 and 3 months).

Results:

At 1 month postop, the mean uncorrected binocular near visual acuity under photopic conditions at 400 cm (far), 70 cm (intermediate) and 40 cm (near) with the ReSTOR +3 IOL (n= 26) was -0.05 ± 0.06, 0.36±0.11 and 0.07±0.06 logMAR respectively, and with the Finevision IOL (n=18) -0.01 ±0.10, 0.29±0.11 and 0.06±0.11 logMAR respectively, with no statistically significant difference. The 1 month post op MRSE was 0.04 ± 0.17 D for the ReSTOR IOL group and 0.00 ± 0.30 D for the Finevision IOL group. Three months results will be discussed during the meeting.

Conclusions:

Good distance, intermediate and near vision was measured with both multifocal IOLs. The 1 month post op results indicate no significant difference in patients implanted with either the AcrySof® IQ ReSTOR® +3 or the Finevision (micro F) IOL.

Financial Interest:

... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a competing company